Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: A prospective observational cohort study

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 5, 2015, Pages 331-338

  Mo, Daojun ^a   Fleseriu, Maria ^b   Qi, Rong ^a   Jia, Nan ^a   Child, Christopher Jeremy ^a   Bouillon, Roger ^c   Hardin, Dana Sue ^a  

^a ELI LILLY AND COMPANY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; EUROPE; FEMALE; FRACTURE; GROWTH HORMONE DEFICIENCY; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE FRACTURE; UNITED STATES; DEFICIENCY; FRACTURES, BONE; MIDDLE AGED; RISK FACTOR;

ADULT; FEMALE; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84928706199     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00098-4     Document Type: Article

References (35)

1. Vestergaard P, Jørgensen JO, Hagen C, et al. Fracture risk is increased in patients with GH deficiency or untreated prolactinomas-a case-control study. Clin Endocrinol (Oxf) 2002, 56:159-167.
2. Wüster C, Abs R, Bengtsson BA, et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001, 16:398-405.
3. Holmer H, Svensson J, Rylander L, et al. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res 2007, 22:1842-1850.
4. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997, 137:240-245.
5. Bouillon R, Koledova E, Bezlepkina O, et al. Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 2004, 89:4993-4998.
6. Giustina A, Mazziotti G, Canalis E Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008, 29:535-559.
7. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006, 91:1621-1634. Endocrine Society's Clinical Guidelines Subcommittee.
8. Barake M, Klibanski A, Tritos NA Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab 2014, 99:852-860.
9. Elbornsson M, Götherström G, Bosæus I, Bengtsson BÅ, Johannsson G, Svensson J Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endrocrinol 2012, 166:787-795.
10. Mazziotti G, Mormando M, Cristiano A, et al. Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Eur J Endocrinol 2014, 170:893-899.
11. Webb SM, Strasburger CJ, Mo D, et al. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database. J Clin Endocrinol Metab 2009, 94:392-399.
12. Eggertsen R, Mellström D Height loss in women caused by vertebral fractures and osteoporosis. Ups J Med Sci 2007, 112:213-219.
13. Xu W, Perera S, Medich D, et al. Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone 2011, 48:307-311.
14. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999, 159:484-490.
15. Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002, 155:176-184.
16. Lane NE Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006, 194(suppl 2):S3-S11.
17. Cox DR Regression models and life-tables. J R Stat Soc Ser B 1972, 34:187-220.
18. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction. Osteoporos Int 1998, 8:S7-80.
19. Lissett CA, Murray RD, Shalet SM Timing of onset of growth hormone deficiency is a major influence on insulin-like growth factor I status in adult life. Clin Endocrinol (Oxf) 2002, 57:35-40.
20. Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999, 84:1919-1924.
21. Bex M, Bouillon R Growth hormone and bone health. Horm Res 2003, 60(suppl 3):80-86.
22. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients-2009 update. Endocr Pract 2009, 15(suppl 2):1-29. American Association of Clinical Endocrinologists.
23. Singer BR, McLauchlan GJ, Robinson CM, Christie J Epidemiology of fractures in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br 1998, 80:243-248.
24. Donaldson LJ, Reckless IP, Scholes S, Mindell JS, Shelton NJ The epidemiology of fractures in England. J Epidemiol Community Health 2008, 62:174-180.
25. Khosla S, Amin S, Orwoll E Osteoporosis in men. Endocr Rev 2008, 29:441-464.
26. van Staa TP, Dennison EM, Leufkens HG, Cooper C Epidemiology of fractures in England and Wales. Bone 2001, 29:517-522.
27. Melton LJ, Crowson CS, O'Fallon WM Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999, 9:29-37.
28. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004, 34:195-202.
29. Osteoporosis: An Evidence-Based Guide to Prevention and Management 2002, American College of Physicans, Philadelphia. S.R. Cummings, F. Cosman, S.A. Jamal (Eds.).
30. Cook DM, Ludlam WH, Cook MB Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 1999, 84:3956-3960.
31. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 2005, 289:266-271.
32. Reid IR Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol 1997, 137:209-217.
33. Ragnar Agnarsson H, Johannsson G, Ragnarsson O The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy. J Clin Endocrinol Metab 2014, 99:1479-1485.
34. Compston JE, Flahive J, Hosmer DW, et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014, 29:487-493.
35. Cooper C, Melton LJ Vertebral fractures. BMJ 1992, 304:793-794.